Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations
PHASE1CompletedINTERVENTIONAL
Enrollment
15
Participants
Timeline
Start Date
April 10, 2017
Primary Completion Date
May 12, 2017
Study Completion Date
May 12, 2017
Conditions
Healthy
Interventions
DRUG
Loteprednol Etabonate
one drop per eye for each eye
Trial Locations (1)
90301
Valeant Site 01, Inglewood
All Listed Sponsors
lead
Bausch & Lomb Incorporated
INDUSTRY
NCT03098953 - Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations | Biotech Hunter | Biotech Hunter